Index Trend Analysis Report
Prepared for you on Saturday, September 24, 2022.
S&P Pan Asia BMI Pharmaceuticals, Biotechnology & Life Sciences (US Dollar) (CME:SPAU22)
Long-Term Downtrend (-90) - SPAU22 is in a strong downtrend that is likely to continue. While SPAU22 is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid SPAU22?
MarketClub looks at technical strength and momentum to determine if the timing is right for SPAU22.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for SPAU22
The long-term trend has been DOWN since Sep 19th, 2022 at 263.99
The intermediate-term trend has been DOWN since Aug 23rd, 2022 at 280.95
The short-term trend has been DOWN since Sep 13th, 2022 at 272.65
Smart Scan Analysis for SPAU22
Based on our trend formula, SPAU22 is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|52wk High||330.41||52wk High Date||2018-09-27|
|52wk Low||269.91||52wk Low Date||2017-12-08|